stella
beta
Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation — Stella
Recruiting
Back to Transthyretin Cardiac Amyloidosis trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(4 sites)
United States
Cedars-Sinai, Beverly Hills, California
Columbia University Medical Center, New York, New York
Cleveland Clinic, Cleveland, Ohio
UT Southwestern Medical Center, Dallas, Texas
View full record on ClinicalTrials.gov